Pacific Biosciences of California (PACB) Ascends While Market Falls: Some Facts to Note
NASDAQ · 18h ago
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
PacBio is using its Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany. Novogene is a leading provider of genomic services and bioinformatics expertise. The Revio is designed to enable customers to scale in-depth genomic research across rare diseases, cancer, microbes.
Barchart · 2d ago
Weekly Report: what happened at PACB last week (0715-0719)?
Weekly Report · 3d ago
BUZZ-Nasdaq biotech index hits over 2-1/2 yr high
Shares of the Nasdaq biotech index up 1.3% at 4.885.99 points in afternoon trading. Index hits over 2-1/2 yr high. Top movers include Pacific Biosciences and Grail. The index has risen 6.8% in the week ended July 12.
Reuters · 07/16 18:01
Pacific Biosciences of California Up Over 32%, on Pace for Largest Percent Increase Since November 2018 -- Data Talk
Dow Jones · 07/16 17:26
PacBio jumps over 30%, biggest in five years
Seeking Alpha · 07/16 17:24
Dow Rallies To All-Time Highs, Small Caps Outperform Tech, Gold Hits Records On Heightened September Rate Cut Bets: What's Driving Markets Tuesday?
Blue-chip stocks and gold break their all-time highs on Tuesday. Dow Jones Industrial Average surged to 40,800 points, marking its best day since late May. Small caps have posted their fifth consecutive day in the green. Fed futures indicate a 100% probability that policymakers will cut interest rates in September.
Benzinga · 07/16 17:20
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
The Charles Schwab Corporation shares dipped 7.5% to $69.42 on Tuesday. The company reported second-quarter results that fell 2% Y/Y. Yoshitsu Co., Ltd. Shares jumped 109% after the company reported a year-over-year increase in financial results.
Benzinga · 07/16 17:06
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
Shares of UnitedHealth Group Incorporated rose sharply on Tuesday following a second-quarter earnings beat. The Dow Jones index gained around 550 points on Tuesday. Logistic Properties of the Americas shares surged 53.8% to $23.71. AngioDynamics, Chegg and Match Group also recorded gains.
Benzinga · 07/16 15:09
Weekly Report: what happened at PACB last week (0708-0712)?
Weekly Report · 07/15 09:26
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
The Bank of New York Mellon Corporation reported better-than-expected quarterly financial results. The Nasdaq Composite index gained around 100 points on Friday. Lucid Group, Inc. Shares jumped 17% to $3.9850 after the company reported better than expected quarterly results. Shares of the bank of new York Mellon also rose.
Benzinga · 07/12 14:27
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
U.S. Stocks were mostly higher on Thursday. Shares of Methode Electronics, Inc. Rose sharply after the company reported better-than-expected fourth-quarter sales results. QuantumScape Corporation shares jumped 25% to $6.76. The Dow Jones index gained around 100 points in Thursday's session.
Benzinga · 07/11 14:10
Weekly Report: what happened at PACB last week (0701-0705)?
Weekly Report · 07/08 09:27
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
NASDAQ · 07/02 15:56
How To Pick Top Pharma Stocks: Novo Nordisk And More
Nine steps I use to identify the most promising pharmaceutical companies and avoid pitfalls. Novo Nordisk is a leader in the fast-growing anti-obesity medicines market. The company has been approved in China to treat people living with obesity. This article includes an analysis of the company and its portfolio of product candidates. The author outlines his methodology for selecting pharmaceutical companies.
Seeking Alpha · 07/02 15:20
Take Care Before Jumping Onto Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even Though It's 33% Cheaper
Pacific Biosciences of California, Inc. Share price has dived 33% in the last 30 days. The company has a price-to-sales ratio of 1.6x and is expected to grow revenue by 17% over the next three years. However, the company's P/S ratio sits behind most of its industry peers.
Simply Wall St · 07/02 10:29
Weekly Report: what happened at PACB last week (0624-0628)?
Weekly Report · 07/01 09:27
Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors
NASDAQ · 06/28 22:15
Barclays Sticks to Their Hold Rating for Pacific Biosciences (PACB)
TipRanks · 06/28 09:32
Cathie Wood’s top and bottom performing ARKK holdings of H1
Seeking Alpha · 06/27 14:17
Webull provides a variety of real-time PACB stock news. You can receive the latest news about Pacific Biosc through multiple platforms. This information may help you make smarter investment decisions.
About PACB
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.